Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS

Tom Delahunty, Lane Bushman, Courtney V. Fletcher

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

An LC/MS/MS assay for the determination of tenofovir (TNF) was developed and validated for use with the EDTA anticoagulated human plasma matrix. Heparin-treated plasma and serum matrices were also validated. After addition of adefovir as an internal standard, trifluoroacetic acid was used to produce a protein-free extract. Chromatographic separation was achieved with a Polar-RP Synergi, 2.0 mm x 150 mm, reversed-phase analytical column. The mobile phase was 3% acetonitrile/1% acetic acid, aq. Detection of TNF and the internal standard was achieved by ESI MS/MS in the positive ion mode using 288/176 and 274/162 transitions, respectively. The method was linear from 10 to 750 ng/ml with a minimum quantifiable limit of 10 ng/ml when 250 μl aliquots were analyzed. The usefulness of this LC/MS/MS method to routinely monitor plasma concentrations of TNF was demonstrated along with its ability to assist in the performance of pharmacokinetic studies.

Original languageEnglish (US)
Pages (from-to)6-12
Number of pages7
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume830
Issue number1
DOIs
StatePublished - Jan 2 2006

Fingerprint

Tenofovir
Assays
Plasmas
Plasma (human)
Trifluoroacetic Acid
Pharmacokinetics
Edetic Acid
Acetic Acid
Heparin
Positive ions
Ions
Serum
Proteins

Keywords

  • Adefovir (PMEA)
  • LC/MS/MS
  • Plasma
  • Tenofovir (TNF)

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this

Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS. / Delahunty, Tom; Bushman, Lane; Fletcher, Courtney V.

In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 830, No. 1, 02.01.2006, p. 6-12.

Research output: Contribution to journalArticle

@article{116c30fb49354ba2930e58001dd04904,
title = "Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS",
abstract = "An LC/MS/MS assay for the determination of tenofovir (TNF) was developed and validated for use with the EDTA anticoagulated human plasma matrix. Heparin-treated plasma and serum matrices were also validated. After addition of adefovir as an internal standard, trifluoroacetic acid was used to produce a protein-free extract. Chromatographic separation was achieved with a Polar-RP Synergi, 2.0 mm x 150 mm, reversed-phase analytical column. The mobile phase was 3{\%} acetonitrile/1{\%} acetic acid, aq. Detection of TNF and the internal standard was achieved by ESI MS/MS in the positive ion mode using 288/176 and 274/162 transitions, respectively. The method was linear from 10 to 750 ng/ml with a minimum quantifiable limit of 10 ng/ml when 250 μl aliquots were analyzed. The usefulness of this LC/MS/MS method to routinely monitor plasma concentrations of TNF was demonstrated along with its ability to assist in the performance of pharmacokinetic studies.",
keywords = "Adefovir (PMEA), LC/MS/MS, Plasma, Tenofovir (TNF)",
author = "Tom Delahunty and Lane Bushman and Fletcher, {Courtney V.}",
year = "2006",
month = "1",
day = "2",
doi = "10.1016/j.jchromb.2005.10.015",
language = "English (US)",
volume = "830",
pages = "6--12",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS

AU - Delahunty, Tom

AU - Bushman, Lane

AU - Fletcher, Courtney V.

PY - 2006/1/2

Y1 - 2006/1/2

N2 - An LC/MS/MS assay for the determination of tenofovir (TNF) was developed and validated for use with the EDTA anticoagulated human plasma matrix. Heparin-treated plasma and serum matrices were also validated. After addition of adefovir as an internal standard, trifluoroacetic acid was used to produce a protein-free extract. Chromatographic separation was achieved with a Polar-RP Synergi, 2.0 mm x 150 mm, reversed-phase analytical column. The mobile phase was 3% acetonitrile/1% acetic acid, aq. Detection of TNF and the internal standard was achieved by ESI MS/MS in the positive ion mode using 288/176 and 274/162 transitions, respectively. The method was linear from 10 to 750 ng/ml with a minimum quantifiable limit of 10 ng/ml when 250 μl aliquots were analyzed. The usefulness of this LC/MS/MS method to routinely monitor plasma concentrations of TNF was demonstrated along with its ability to assist in the performance of pharmacokinetic studies.

AB - An LC/MS/MS assay for the determination of tenofovir (TNF) was developed and validated for use with the EDTA anticoagulated human plasma matrix. Heparin-treated plasma and serum matrices were also validated. After addition of adefovir as an internal standard, trifluoroacetic acid was used to produce a protein-free extract. Chromatographic separation was achieved with a Polar-RP Synergi, 2.0 mm x 150 mm, reversed-phase analytical column. The mobile phase was 3% acetonitrile/1% acetic acid, aq. Detection of TNF and the internal standard was achieved by ESI MS/MS in the positive ion mode using 288/176 and 274/162 transitions, respectively. The method was linear from 10 to 750 ng/ml with a minimum quantifiable limit of 10 ng/ml when 250 μl aliquots were analyzed. The usefulness of this LC/MS/MS method to routinely monitor plasma concentrations of TNF was demonstrated along with its ability to assist in the performance of pharmacokinetic studies.

KW - Adefovir (PMEA)

KW - LC/MS/MS

KW - Plasma

KW - Tenofovir (TNF)

UR - http://www.scopus.com/inward/record.url?scp=29244491123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244491123&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2005.10.015

DO - 10.1016/j.jchromb.2005.10.015

M3 - Article

C2 - 16269276

AN - SCOPUS:29244491123

VL - 830

SP - 6

EP - 12

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 1

ER -